Below you'll find a list of all posts that have been tagged as “MGB Biopharma”
MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, today announces the completion of its latest funding round.
MGB Biopharma’s anti-bacterial agent for treatment of C. difficile infections, helped by Archangels funding round, to enter Phase II clinical trials
Spreng Thomson: Intelligent Creative Communications
Spreng Thomson is committed to Fair Work, by ensuring that our people have an effective voice, by investing in their development and by not using zero hours contracts.
+44(0)141 548 5191
[email protected]
The Herald Building,
155 Albion Street,
Glasgow G1 1RU, UK
© 2025 Spreng Thomson Limited.
Registered in Scotland No. 173454
